Biofrontera (BFRI) Net Margin (2020 - 2025)

Biofrontera's (BFRI) quarterly Net Margin came in at 46.04% in Q4 2025, up 5715.0% year-on-year from 0.79% in Q4 2024, and up 148.38% quarter-over-quarter from 95.15% in Q3 2025.

Biofrontera (BFRI) Net Margin (2020 - 2025) Analysis & Trends

Biofrontera's Net Margin history runs 6 years deep, the most recent figure standing at 46.04% for Q4 2025.

  • On a quarterly basis, Net Margin rose 5715.0% year-over-year to 46.04% in Q4 2025; TTM through Dec 2025 was 19.91%, a 2767.0% increase from a year earlier, with the FY2025 full-year figure at 19.91%, up 2767.0% from the prior year.
  • Net Margin advanced to 46.04% in Q4 2025 per BFRI's latest filing, from 95.15% in the prior quarter.
  • Across five years, Net Margin topped out at 97.51% in Q4 2021 and bottomed at 369.45% in Q3 2021.
  • The 5-year median for Net Margin is 59.16% (2022), against an average of 55.8%.
  • Across the five-year window, Net Margin plunged 27766 bps in 2021 and jumped 31008 bps in 2022, its largest moves.
  • Year by year, Net Margin stood at 97.51% in 2021, then tumbled by 128 bps to 27.45% in 2022, then soared by 221 bps to 33.28% in 2023, then tumbled by 133 bps to 11.12% in 2024, then jumped by 514 bps to 46.04% in 2025.
  • Per Business Quant, the three latest BFRI Net Margin figures stand at 46.04% (Q4 2025), 95.15% (Q3 2025), and 58.96% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 46.04%

Historic Data

Download Data
DateValue
Dec 31, 2025 46.04%
Sep 30, 2025 -95.15%
Jun 30, 2025 -58.96%
Mar 31, 2025 -48.94%
Dec 31, 2024 -11.12%
Sep 30, 2024 -62.91%
Jun 30, 2024 -3.28%
Mar 31, 2024 -131.91%
Dec 31, 2023 33.28%
Sep 30, 2023 -71.29%
Jun 30, 2023 -168.21%
Mar 31, 2023 -85.63%
Dec 31, 2022 -27.45%
Sep 30, 2022 -59.37%
Jun 30, 2022 -19.07%
Mar 31, 2022 57.03%
Dec 31, 2021 97.51%
Sep 30, 2021 -369.45%
Jun 30, 2021 -62.53%
Mar 31, 2021 -74.49%